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Objectives: To evaluate if ‘wrap therapy’ using food
wraps, which is widely used in Japanese clinical sites,
is not inferior when compared to guideline adhesion
treatments.
Design: Multicentre, prospective, randomised, open,
blinded endpoint clinical trial.
Setting: 15 hospitals in Japan.
Patients: 66 older patients with new National Pressure
Ulcer Advisory Panel stage II or III pressure ulcers.
Interventions: Of these 66 patients, 31 were divided
into the conventional treatment guidelines group and
35 into the wrap therapy group.
Main outcome measures: The primary end point
was the period until the pressure ulcers were cured.
The secondary end point was a comparison of the
speed of change in the Pressure Ulcer Scale for
Healing score.
Results: 64 of the 66 patients were analysed. The
estimated mean period until healing was 57.5 days
(95% CI 45.2 to 69.8) in the control group as opposed
to 59.8 days (95% CI 49.7 to 69.9) in the wrap therapy
group. By the extent of pressure ulcer inﬁltration, the
mean period until healing was 16.0 days (95% CI 8.1
to 23.9) in the control group as opposed to 18.8 days
(95% CI 10.3 to 27.2) in the wrap therapy group
with National Pressure Ulcer Advisory Panel stage II
ulcers, and 71.8 days (95% CI 61.4 to 82.3) as
opposed to 63.2 days (95% CI 53.0 to 73.4),
respectively, with stage III ulcers. There is no
statistical signiﬁcance in difference in Pressure Ulcer
Scale for Healing scores.
Conclusions: It might be possible to consider
wrap therapy as an alternative choice in primary
care settings as a simple and inexpensive dressing
care.
Clinical Trial registration: UMIN Clinical Trials





Among the health problems speciﬁc to the
frail older people, pressure ulcer
1e3 has been
a major health problem, and the establish-
ment and spread of an effective treatment
method for it has been a pressing issue. After
guideline publication by Agency for Health-
Care Policy and Research,
4 there have
been few standard policy announcements
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- ‘Wrap therapy’ is a method for localised care of
pressure ulcers using polyethylene sheets, such
as in food wraps, to the pressure ulcers. There
are numerous case reports promoting efﬁciency
of this therapy in Japan.
- We hypothesised non-inferiority of the efﬁcacy of
wrap therapy on adult patients with pressure
ulcers classiﬁed as National Pressure Ulcer
Advisory Panel stage II or III comparing with
that of guideline adhesion treatment to Japanese
patients.
Key messages
- The survival curves did not show the inferiority of
wrap therapy comparing with guideline adhesion
treatment on the period until the pressure ulcers
healed.
- The result of this study implies clinical utility of
wrap therapy, which has been reported many
times in Japanese academic conferences
concerned with wound healing and treatment of
the older people. Bigger sample trials are
necessary to conﬁrm this implication as rigorous
clinical evidence.
Strengths and limitations of this study
- This is the ﬁrst study revealing the efﬁcacy of
wrap therapy, that is inexpensive and simple for
home care, using randomised controlled trail
design.
- Relatively weak statistical power and impossi-
bility of blindness of the treatment.
Bito S, Mizuhara A, Oonishi S, et al. BMJ Open 2012;2:e000371. doi:10.1136/bmjopen-2011-000371 1
Open Access Researchregarding localised treatments with high evidence
levels.
56The Japanese Society of Pressure Ulcers (JSPU)
published its ‘Evidence-Based Localized Pressure Ulcer
Treatment Guidelines’ in 2005, and treatments based on
these have become the conventional treatments in
Japan.
7 According to the guidelines, overall complex
treatments aiming to debride necrotic tissue and reduce
the ulcers are recommended for deep pressure ulcers.
However, the recommendation grades regarding indi-
vidual ointments and dressings, physical treatments and
surgical treatments are low level. Several intervention
researches have been performed on speciﬁc drugs in
localised treatments, but few clinical breakthrough
methods have been discovered in the effects of these
interventions.
8e14
‘Wrap therapy’ is a method for localised care of pres-
sure ulcers through which healing can be expected
based on the natural healing effects by applying poly-
ethylene sheets, such as in food wraps, to the pressure
ulcers. This method has spread following its proposal by
Toriyabe et al.
15 On the effectiveness of wrap therapy in
treating pressure ulcers, and of their simplicity and low
cost, there are numerous case reports and case series
research supporting no-inferiority of wrap therapy in
Japan.
16e20 On March 2010, JSPU approved wrap
therapy as one of the ﬁrst treatment choices in limited
situations.
Our purpose was to evaluate the efﬁcacy of wrap
therapy on adult patients with pressure ulcers classiﬁed
as National Pressure Ulcer Advisory Panel (NPUAP)
stage II or III on their backs using the current conven-
tional treatment in Japan, described in the guideline
published by JSPU, as a control. If this research veriﬁes
that wrap therapy is not harmful and has equivalent or
better efﬁcacy compared to conventional treatments,
a low-cost treatment method can be well applied to the
care of older people.
METHODS
Study design and setting
The study evaluated outcomes and analysis of the
prospective, randomised, open, blinded endpoint trial at
numerous facilities. For this study, we recruited facilities
by appealing to them for participation via mailing lists
related to JSPU and those regarding pressure ulcer
diagnosis and treatment. To assure implementation of
the research work, we set the following as suitable stan-
dards for the facilities sharing the work: facilities that
were able to use body pressure diffusion mats for
patients with pressure ulcer, facilities with experience of
wrap therapy on some patients, the existence of care
systems for pressure ulcer care and environments that
were able to perform pressure ulcer treatments during
hospitalisation. Fifteen hospitals ﬁnally were identiﬁed
to be eligible facilities.
Patients and randomisation
For patient registration, we set the following inclusion
and exclusion criteria: patients aged 50 years or older
with one or more NPUAP stage II or III pressure ulcers
on either their torso or trochanter, body temperature of
35.58C minimum to 37.58C maximum, 600 kcal or over
daily intake, no critical nutritional impairment, renal
failure, cirrhosis, immunosuppression, uncontrollable
diabetes or malignant tumours according to an exami-
nation performed within past 4 weeks. End-of-life
patients whose estimated alive period was <3 months
were excluded. When the patient did not possess the
ability to make the autonomous decision to participate
in the study, the outline and methods of the research
were explained to their representing immediate family
member, from whom written consent was obtained. After
obtaining written consent, then uncoordinated random
allocations were performed at the registration centre in
the research ofﬁce within 24 h.
Prospective, randomised, open, blinded endpoint
design was applied for this study because blinding two
different interventions was impossible in clinical setting.
We adopted non-stratiﬁed pure random allocation for
randomisation of the enrolled patients. If health staff
obtained informed consent from eligible patients, then
they send fax to the allocation centre located at Higashi-
Washinomiya Hospital with basic information, including
location and stage of pressure ulcers. The allocation
centre ﬁnally decided eligibility and inform registration
conﬁrmation and allocation results to the facilities by fax
within 48 h of the reception.
Interventions
Wrap therapy was deﬁned as a method of treatment that
uses food wraps and perforated polyethylene as a wound
dressing. In many cases, wrap therapy follows the
procedure of thoroughly irrigating the pressure ulcers
(ﬁgure 1A) before directly covering the pressure ulcers
with food wrap if the exudation is small or with
commercially available perforated polyethylene sheets
and diapers or with a cover sheet combined with sanitary
towels if the exudation is great (ﬁgure 1B,C). Irrigation
and the covering process are performed every day.
21
To standardise the categories and treatment proce-
dures of wrap therapy as much as possible, a meeting for
instruction of interventions was held beforehand. A DVD
of the lecture was distributed to the physicians who were
unable to participate in the instruction meeting.
Patients allocated to the control group were
treated using methods conforming the ‘Evidence-Based
Localized Pressure Ulcer Treatment Guidelines’ issued
by JSPU.
7 The diagnosis and treatment guidelines
are created by JSPU based on current diagnosis and
treatment evidence.
Outcomes evaluated
The primary end point was deﬁned as the period from
the start of registration until the pressure ulcers that had
been the subject of observation for 3 months were
healed. After the patient had been discharged from the
hospital, continuous observation was performed as far as
possible through diagnosis and treatment at home.
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Wrap therapy for pressure ulcersEvery wound heal was conﬁrmed by supervising physi-
cians. As the secondary end point, we measured the
Pressure Ulcer Scale for Healing (PUSH) score for the
localised status of the pressure ulcers as deﬁned by
NPUAP at 2, 4, 6, 8, 10 and 12 weeks from the start of
registration.
22
Method for blinded endpoint evaluation
To avoid the occurrence of observation bias, we estab-
lished an ‘outcome evaluation centre’. Digital camera
images were sent from every facility to the outcome
evaluation centre, and all outcomes were evaluated
there. The outcome evaluation centre was blinded so as
not to know the treatment group to which the subject
belonged. Because it was impossible to evaluate the
exudates amount using images, records were made by
the observer directly. In case the outcome evaluation
centre found some problems that excuse the leakages of
blindness, then that was reported to the administration
ofﬁce immediately.
We also recorded the total amount of ointment used in
localised treatments during the observation period and
performed rough calculations with regard to cost.
Adverse events and role of the patient safety monitoring
board
A safety evaluation committee was established
comprising several specialists and non-specialists. The
members were independent of the patient registration,
research ofﬁces and the outcome evaluation centre. In
all cases of death, worsening of the pressure ulcers
during the research period, systemic deterioration or
sepsis occurring within 30 days from the day of the
protocol treatment and when the connection to
the pressure ulcers was undeniable, researchers sharing
the research at the core facilities reported to the
committee.
Statistical analysis
We aimed to clarify our statistical hypothesis that wrap
therapy was not inferior compared to conventional
treatments conforming to the guidelines. The mean
period until healing for the localised treatment of stage
II pressure ulcers was set as 21 days based on previous
literature.
9e14 The non-inferior threshold was set at
7 days according to clinical judgement. When set to
a tolerable threshold difference of 7 days, when one side
has a 5% signiﬁcance level and a test power of 90%, the
required number of cases in the two cohorts was 80.
Similarly, the required number of cases for stage III
pressure ulcers was 60. For the total number of target
cases, the number of target registered patients was 140.
The analysts were blinded about which group was the
wrap therapy or the conventional treatment until the
analysis was ﬁnished. Intention-to-treat analysis was
performed.
For the main endpoint comparisons, KaplaneMeier
plots were created, and the estimated mean value until
the endpoint occurrence and its 95% CI were calculated.
The differences in the PUSH scores were calculated
from 2 weeks immediately after the start of observations,
between 2e4 weeks, 4e6 weeks, 6e8 weeks, 8e10 weeks
and 10e12 weeks and described the speed of pressure
ulcer healing over time for both groups. We used PASW
Statistics V.18 (SPSS, Inc) for the statistical analysis.
RESULTS
We started recruitments in October 2009 and followed
until May 2010. The study ﬂow diagram is shown in
ﬁgure 2. During the research period, a total of 66
patients participated. Of these, two could not be
followed-up due to early discharge or transfer to another
hospital. A total of 64 participants were analysed: 29 in
the conventional treatment group and 35 in the wrap
therapy group. The percentage of patients whose end
points could be pursued 4 weeks after registration was
95%, 8 weeks after registration was 77% and 12 weeks
after registration was 64%. The characteristics distribu-
tion of the patients analysed was 33 females and 29
males, and the locations of the target pressure ulcers
were most common on the sacrum (56%), followed by
the trochanter (13%), gluteus (6%) and the coccyx
(5%).
Table 1 shows a comparison of the patients’ charac-
teristics distribution, their health at registration, the
status of their pressure ulcers and the treatment method
for the two groups. The mean values in the conventional
treatment and wrap therapy cohorts were 12.7 versus 12.7
for the Braden Scale at registration.
23 The percentages
using hydrocolloids, hydrogels or polyurethane foam as
Figure 1
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Wrap therapy for pressure ulcerspressure ulcer dressings were 76% in the control group
and 3% in the intervention cohort.
Time until the pressure ulcers healed
The percentage of patients in whom healing of the
pressure ulcers was veriﬁed from among the samples that
could be followed-up at 4 weeks after registration were
26% of the conventional group as opposed to 21% in the
wrap therapy group; at 8 weeks after registration, the
percentages were 46% in the conventional group as
opposed to 52% in the wrap therapy group.
Figure 3A shows the survival curves of both groups.
The mean of the estimated value until healing was
57.5 days (95% CI 45.2 to 69.8) for the conventional
group as opposed to 59.8 days (95% CI 49.7 to 69.9) for
the wrap therapy group. Figure 3B,C describes the
survival curve for the patients with NPUAP stage II and
III pressure ulcers, respectively. For stage II pressure
ulcers, the estimated mean value until healing were
16.0 days (95% CI 8.1 to 23.9) for the conventional
group compared to 18.8 days (95% CI 10.3 to 27.2) for
the wrap therapy group. Meanwhile, for stage III pres-
sure ulcers, the estimated mean value until healing were
71.8 days (95% CI 61.4 to 82.3) for the conventional
group compared to 63.2 days (95% CI 53.0 to 73.4) for
the wrap therapy group.
Speed of pressure ulcer healing using PUSH scores
The mean values of the difference in the PUSH scores at
registration and upon either healing or the ﬁnal obser-
vation divided by the treatment period were 1.162.1
points in the conventional group and 0.961.3 points
in the wrap therapy group (p¼0.73 Student t test).
No signiﬁcant difference was identiﬁed in the mean
PUSH score reduction values in either cohort from
immediately after the start of observations to the second
week, from the second to the fourth week, from the
fourth to the sixth week, from the sixth to the eighth
week, from the eighth to the 10th week and from the
10th to the 12th week (table 2).
Adverse events
During the total observation period, there was systemic
worsening, such as pneumonia, occurring immediately
after the start of observation in three cases in the
conventional group and in four cases in the wrap
therapy group. Two cases in the conventional group died
of pneumonia and one died of heart failure for a total of
three deaths. In the wrap therapy group, one patient
died of pneumonia and one died of senescence for
a total of two deaths. Regarding localised adverse events,
there were problems with the covered skin (eczema,
maceration, rash, etc) in the conventional group and six
cases in the wrap therapy group.
DISCUSSIONS
Statement of principal ﬁndings
‘Wrap therapy’ has already been introduced nationwide
in Japanese clinical facilities. The main reasons for its
spread in clinical settings are both that wrap therapy is
a rational treatment method compared to basic wound-
healing therapies, in that it is possible to maintain
a lubricated environment without applying stress to the
wound,
24 25 and because compared to complex pressure
ulcer treatments that combine various ointments and
dressings, it has frequently been recognised empirically
in actual clinical settings as having equal or better effects
in treating pressure ulcers.
Looking only at the main outcome survival curves, and
taking all the patients into consideration, almost
Figure 2 Study ﬂow diagram.
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Wrap therapy for pressure ulcersidentical results were obtained in both the wrap therapy
and conventional treatment groups for the period until
the pressure ulcers healed. Meanwhile, when the two
treatment groups are compared using the NPUAP clas-
siﬁcation, although no clear difference between the
survival curves of the two treatments were identiﬁed with
shallow stage II pressure ulcers, in the comparison
between the stage III pressure ulcer cohorts, the survival
curve of the wrap therapy cohort showed that healing
tended to be faster than in the conventional treatment
cohort. No statistical signiﬁcance, however, was
presented in this study. We cannot state so far that wrap
therapy should be chosen as the ﬁrst recommended
therapy to shorten the healing time of pressure ulcer.
Further study with bigger sample is needed to ensure
these visual differences in survival curves. Nor was any
signiﬁcant difference identiﬁed between the wrap
therapy and conventional treatment cohorts regarding
the extent of PUSH score reduction either, and this
result can also be stated to support the fact that wrap
therapy is not inferior to conventional treatments.
Nevertheless, initially, we estimated 80 cases and 60 cases
in the NPUAP classiﬁcation subgroups as the non-infe-
rior estimate, but on this occasion, the total effective
sample, at 64 cases, lacked sufﬁcient statistical power.
During the comparison of adverse events, there were
concerns that skin problems caused by food wraps and
perforated polyethylene used in the wrap therapy might
occur, but in our research, no signiﬁcant difference was
identiﬁed with the results of the conventional treat-
ments. Rashes due to adhesive plasters and tape were
identiﬁed in four cases in the conventional cohort, but
none were observed in the wrap therapy cohort. This is
thought to be because it is basically possible to imple-
ment wrap therapy merely by making the patient wear
paper diapers without afﬁxing tape after applying the
dressing.
Strengths and weakness of the study
This research is the world’s ﬁrst randomised controlled
trials that compares conventional treatments and wrap
therapy. Theoretical superiority of wrap therapy to
conventional treatments conforming to guidelines is the
simplicity and cost-effectiveness of the treatment.
20 26
Conventional treatments require the use of multiple
ointments and dressings of suitable size and type, and
the treatment requires a certain level of specialist skills.
The simplicity of treatment protocols using wrap therapy
might better promote the spread of care skills.
Regarding cost-effectiveness, the various ointments and




cohort (n[35) p Value
Mean age (years) 82610 81612 0.60
Sex (female %) 48 54 0.28
Nutrition absorption status (each %)
Oral nutrition 52 49 0.27
Enteral alimentation: nasally 0 9
Enteral alimentation: gastrostoma 38 40
Central venous nutrition 10 3
Use of pressure-resistant diffusion mattress
(percentage ‘Yes’)
93 100 0.20
Use of diapers (percentage ‘Yes’) 90 91 0.97
Depth of target pressure ulcer
NPUAP stage II (%) 28 11 0.09
NPUAP stage III (%) 72 89
Pressure ulcer pockets (% present) 38 34 0.28
Calories absorbed (each %)
Over 1200 kcal 45 49 0.58
800e1200 kcal 45 37
600e800 kcal 10 9
Serum albumin (mean6SD) 2.860.5 2.960.5 0.61
Serum creatinine (mean6SD) 0.6660.3 0.6460.3 0.77
Braden Scale at registration (mean6SD) 12.863.5 12.762.8 0.89
Pressure Ulcer Scale for Healing score at
registration (mean6SD)
10.862.6 10.762.7 0.91
Pressure ulcer surface area at registration
(mean6SD)
14621 15625 0.79
Use of ointments or sprays including pharmaceuticals
with tissue regeneration accelerant actions
21 14 0.006
Percentage using hydrocolloids, hydrogels or
polyurethane foam as a pressure ulcer dressing
76 3 <0.0001
We used Student t test for comparison of mean values of the two groups. c
2 Test was adopted for comparisons of frequency.
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Wrap therapy for pressure ulcersdressings such as hydrocolloid used in pressure ulcer
treatments are often expensive, but the perforated
polyethylene and diaper sheets used in wrap therapy can
be supplied at <10 cents per treatment. If the acceler-
ated pressure ulcer healing effects of wrap therapy are
the same as those of conventional treatments, the efﬁ-
ciency of wrap therapy is presumably extremely great
when considering cost-effectiveness. Larger scale addi-
tional tests strengthening the veriﬁed backing of these
research results could offer new, simple and effective
Figure 3 (A) Comparison of survival curves using the period until pressure ulcers healing as the end pointdall cases. Y axis
means the proportion of patients who has not been conﬁrmed healing of pressure ulcers. The distribution curves represent the
results of an intention-to-treat survival analysis involving all patients in A, NPUAP stage II patients in B and NPUAP stage III
patients in C. Blue line: conventional treatment cohort. Green line: wrap therapy cohort. Estimated mean period until healing (95%
CI). Conventional treatment cohort: 57.5 days (45.2 to 69.8 days). Wrap therapy cohort: 59.0 days (49.7 to 69.9 days). p¼0.75 log-
rank (ManteleCox) test. (B) Comparison of survival curves using the period until pressure ulcers healing as the end pointdNPUAP
stage II pressure ulcers cohort. Blue line: conventional treatment cohort. Green line: wrap therapy cohort. Estimated mean period
until healing (95% CI). Conventional treatment cohort: 16.0 days (8.1 to 23.9 days). Wrap therapy cohort: 18.8 days (10.3 to
27.2 days). p¼0.42 log-rank (ManteleCox) test. (C) Comparison of survival curves using the period until pressure ulcers healing as
the end pointdNPUAP stage III pressure ulcers cohort. Blue line: conventional treatment cohort. Green line: wrap therapy cohort.
Estimated mean period until healing (95% CI). Conventional treatment cohort: 71.8 days (61.4 to 82.3 days). Wrap therapy cohort:
63.2 days (53.0 to 73.4 days). p¼0.42 log-rank (ManteleCox) test.
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Wrap therapy for pressure ulcersmethods of pressure ulcer care and noticeably improve
the beneﬁts to both patients and society.
This research, on the other hand, has some limita-
tions. The greatest concern was impossibility of blind-
ness of the treatment. Without blindness, health staff
may have biases on the treatments themselves and
wound evaluations. To minimise observation bias, we
attempted to eliminate bias occurring during the evalu-
ations by combining all the outcomes in a single
outcome evaluation centre as far as possible. The second
limitation resulted in bias among the participating
facilities. Wrap therapy is currently viewed as an alter-
native treatment of choice. The facilities that partici-
pated in this research currently use wrap therapy
clinically under this present condition, and the possi-
bility of wrap therapy effects being overvalued before-
hand cannot be denied.
Practical applications
When we consider clinical application of wrap therapy,
we should pay some attentions. First, because wrap
therapy is simple and inexpensive method, it may be
accepted for practical application in home care and
primary care setting. Many primary care physicians and
nurse practitioners are not familiar with complex
protocols using new-coming modern dressings, which
have additional advantages for quality of life for patients,
and wrap therapy may be a useful application as an
initial intervention for pressure ulcers. If wrap therapy is
not effective, then using other modern dressings should
be considered. Second, this attractive method has ethical
concerns. Wrap therapy is not be approved as a formal
medical intervention, which is covered social health
insurance in Japan. Because this therapy uses food
wrapping sheet without sterilisation, approval as an
insured health intervention by Japanese Ministry of
Health, Labour and Welfare is difﬁcult. All devises for
wrap therapy are so far prepared by health providers as
voluntary actions. Even this therapy is useful for home-
care setting, it should be examined under supervision of
well-trained health professionals.
Meaning of the study
Even though our conclusions failed empirical statement
of effectiveness of wrap therapy directly, the results
would not deny actual situations in current Japanese
clinical settings. In future, as the rapid ageing of the
population progresses worldwide, the problem of caring
for the frail older people in Japan, which has the highest
rate of population ageing in the world, will become
a highly compelling problem in the societies of Europe
and North America. Wrap therapy may be an epoch-
making method of treatment, and the veriﬁcation of its
usefulness by clinical experiment is thought to be
a major advance for the future elderly care.
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